APA (7th ed.) Citation

M, A., G, K., K, E. A., E, A. M., M, A., S, A. A., . . . A, A. (2026). Expert opinion on improving influenza vaccination coverage rate in Qatar: Strategic solutions and role of live attenuated influenza vaccine (LAIV). Human vaccines & immunotherapeutics, 22(1), 2628383. https://doi.org/10.1080/21645515.2026.2628383

Chicago Style (17th ed.) Citation

M, Al-Maslamani, et al. "Expert Opinion on Improving Influenza Vaccination Coverage Rate in Qatar: Strategic Solutions and Role of Live Attenuated Influenza Vaccine (LAIV)." Human Vaccines & Immunotherapeutics 22, no. 1 (2026): 2628383. https://doi.org/10.1080/21645515.2026.2628383.

MLA (9th ed.) Citation

M, Al-Maslamani, et al. "Expert Opinion on Improving Influenza Vaccination Coverage Rate in Qatar: Strategic Solutions and Role of Live Attenuated Influenza Vaccine (LAIV)." Human Vaccines & Immunotherapeutics, vol. 22, no. 1, 2026, p. 2628383, https://doi.org/10.1080/21645515.2026.2628383.